Overview


According to FutureWise analysis the market for antibody purification services in 2023 is US$ 1 billion, and is expected to reach US$ 2.34 billion by 2031 at a CAGR of 11.22%.

Antibody purification services can simplify the process of extracting antibodies from antiserum or hybridoma and cell cultures. antibodies). Antibodies that were generated as monoclonal antibody hybridoma cell lines and developed as ascites fluid or cell culture supernatant can be completely purified without using an antigen-specific affinity method because the target antibody is the only immunoglobulin in the production sample. In contrast, for polyclonal antibodies from serum samples, it is essential to use antigen-specific affinity purification to prevent co-purification of nonspecific immunoglobulins. Immunoglobulins can be purified via affinity binding to immobilized protein A or protein G particles or other means of affinity chromatography. Purified, ready-to-use antibodies should be the end product.

Purification methods vary from extremely crude to highly specific and are classified as Physicochemical fractionation, Class-specific affinity, and Antigen-specific affinity. Antigen-specific antibody purification is the method of choice for most researchers when antibodies have been generated against peptides. This process allows maximum isolation and enrichment of only the most specific antibodies generated to the antigen while removing other unwanted pre-immune antibodies. Many applications, such as IHC and IF, benefit from this process as antibodies can be used at higher concentrations (lower dilutions) without increasing signal background. Once antiserum has been selected for purification, it is pooled, and the IgG fraction of the antibody is isolated by ammonium sulfate precipitation. This removes many of the sticky proteins from the antiserum and enables a cleaner material preparation to undergo the affinity column.

FutureWise Market Research has published a report that provides an insightful analysis antibody purification services market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antibody purification services market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Thermo Fisher
  • Detai Bio-Tech Co
  • Cusabio
  • Genscript
  • KMD Bioscience
  • SouthernBiotech
  • Pacific Immunology
  • COVALAB
  • Envigo
  • GE Healthcare
  • Rockland
  • Creative Biolabs
  • Abcam
  • BBI Solutions
  • Karebay Bio
  • HuaBio
  • Antibodies Inc
  • Davids Biotechnologie GmbH
  • ProSci Inc
  • Bio-Rad

(Note: The list of the major players will be updated with the latest market scenario and trends)

The growing prevalence of monoclonal antibodies in various therapeutic fields like autoimmune disorders, oncology, and infectious diseases has increased the demand for antibody purification services. Monoclonal antibodies are specifically targeted to disease-causing agents, making them invaluable tools in precision therapy. In oncology, they are deployed to precisely target cancer cells, alleviating damage to healthy tissue. In autoimmune disorders, they help regulate unusual immune responses, providing a promising path for treatment. Also, monoclonal antibodies are used in infectious diseases to neutralize pathogens, offering a potent weapon against growing infectious agents. Moreover, technological advancements in antibody purification processes, including protein A/G/L chromatography, protein L affinity chromatography, and high-resolution chromatographic methods, are anticipated to drive the target market. These advancements have transformed the effectiveness and specificity of antibody purification processes. Protein A/G/L chromatography uses the binding affinity of these proteins to antibodies, allowing highly selective purification. Protein L affinity chromatography caters to antibody subclasses that may not bind well to protein A/G. Additionally, high-resolution chromatography offers excellent separation abilities, reducing the isolation of antibodies from complex mixtures with exceptional precision. However, the high cost of complex techniques and equipment significantly restraints the antibody purification services market. This also poses a significant hindrance for smaller research laboratories and institutions operating with limited budgets. Therefore, impeding the growth of the antibody purification services market.

By Type

  • Physicochemical Fractionation
  • Class-specific Affinity
  • Antigen-specific Affinity

By Application

  • Monoclonal Antibodies
  • Polyclonal Antibodies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to the increasing use of antibodies in the field of proteomics, the presence of many large biotechnology and pharmaceutical firms, growing demand for therapeutic antibodies, rapid growth in healthcare and research infrastructure, increasing focus on drug discovery, and rising demand for protein-based drugs in the area is likely to fuel the growth of antibody purification services market. In addition, increasing R&D activities, regulatory approvals, a growing number of companies offering customized antibody production and purification services, availability of outsourcing options, and technical expertise in antibody production and antigen designing are some factors projected to drive market revenue growth over the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antibody Purification Services Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antibody Purification Services Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antibody Purification Services Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antibody Purification Services Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antibody Purification Services Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Physicochemical Fractionation
        2. Class-specific Affinity
        3. Antigen-specific Affinity

  • 8.   Antibody Purification Services Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Monoclonal Antibodies
        2. Polyclonal Antibodies

  • 9.   North America Antibody Purification Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Antibody Purification Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Antibody Purification Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Antibody Purification Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Detai Bio-Tech Co
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cusabio
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Genscript
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. KMD Bioscience
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. SouthernBiotech
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Pacific Immunology
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. COVALAB
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Envigo
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. GE Healthcare
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Rockland
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Creative Biolabs
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Abcam
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. BBI Solutions
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Karebay Bio
         15.1. Company Overview
            15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. HuaBio
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Antibodies Inc
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Davids Biotechnologie GmbH
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. ProSci Inc
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Bio-Rad
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Deoxyribonucleic Acid (DNA) Purification Market

Read More
Partner

Our Clients